glp 1 weight loss indication Indications for GLP-1/GIP RA Summary Sheet and Beyond! GLP-1 agonists for weight loss:

A recent study reveals a surge in the use of GLP-1 medications, such as Ozempic and Wegovy, among younger age groups

those having a BMI equal to or greater than 25 kg/m2 but less than 30 kg/m2, prevalence more than doubles to 4 billion1

Use of glucagon-like peptide 1 agonists for weight loss compared with bupropion-naltrexone was associated with an increased risk for pancreatitis, gastroparesis and bowel obstruction but not biliary disease, researchers reported in JAMA

Does Anthem Blue Cross Blue Shield cover weight loss treatment in Arizona

For example, a large-scale retrospective study using data from the US Department of Veterans Affairs showed GLP-1 use to be associated with a reduced risk of 42 conditions in a diabetic population1